Faruqi & Faruqi, LLP is Investigating Quest Diagnostics Incorporated (DGX) on Behalf of its Shareholders
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential misconduct at Quest Diagnostics Incorporated (“Quest Diagnostics” or the “Company”) (NYSE:DGX).
The investigation focuses on whether the Company’s Board of Directors and/or its officers breached their fiduciary duties.
Request more information now by clicking here: www.faruqilaw.com/DGX. There is no cost or obligation to you.
If you currently own Quest Diagnostics stock and have continuously owned Quest Diagnostics stock and would like to discuss your legal rights, please fill out the form belowX. You can also contact us by calling Alex B. Heller toll free at (877) 247-4292 or by sending an e-mail to email@example.com. Faruqi & Faruqi, LLP also encourages anyone with information regarding Quest Diagnostics’ conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
Quest Diagnostics Incorporated (DGX)
* The submission of this form does not create an attorney-client relationship.
Filed on 06/06/2019
1617 JFK Boulevard, Suite 1550
19103 Philadelphia, Pennsylvania
Phone (215) 277-5770
Fax (215) 277-5771
Alex B. Heller firstname.lastname@example.org Phone (215) 277-5770 Fax (215) 277-5771